Juliet N. Barker, MBBS

Director, Cord Blood Transplantation Program
Juliet N. Barker, MBBS -- Director, Cord Blood Transplantation Program

I am a bone marrow transplant specialist with expertise in allogeneic transplantation, the use of hematopoietic (blood-forming) stem cells from a donor other than the patient to treat blood and bone marrow diseases. I am particularly interested in the use of umbilical cord blood from healthy newborns as a source of stem cells. While transplantation of stem cells from a healthy sibling or an unrelated volunteer adult donor can cure many patients with blood diseases, patients often do not have a suitably matched donor, especially patients of Southern European, mixed, and non-European (e.g. Hispanic, African, or Asian) backgrounds. In addition, searches for unrelated donors can be unacceptably slow.

Cord blood is an alternative source of hematopoietic stem cells and has a number of advantages over blood or bone marrow from an unrelated donor: it is less important to find a perfect HLA (tissue type) match; cord blood is more rapidly available; and there is a lower risk of a serious transplant complication called graft-versus-host disease, which occurs when the transplanted cells attack the body's normal tissues.

Appointments for New Patients
877-836-ABMT (2268)
Clinical Expertise

Allogeneic Hematopoietic Stem Cell Transplantation; Cord Blood Transplantation

Languages Spoken

MBBS, University of Adelaide (Australia)


Royal Adelaide Hospital (Australia); Westmead Hospital (Australia)


University of Minnesota

Board Certifications

Internal Medicine (Australia)

Publications by Juliet N. Barker
Visit PubMed for full listing of Juliet N. Barker journal articles
Pubmed is an online index of biomedical articles maintained by the U.S. National Library of Medicine and the National Institutes of Health.